Press "Enter" to skip to content

Eli Lilly seeks EUA from FDA for Covid-19 antibody treatment

Eli Lilly and Company’s monoclonal antibody combination therapy reduced virus levels, hospitalizations and emergency room visits in patients with mild-to-moderate Covid-19, the pharmaceutical company said Wednesday.

cnn topstories?d=yIl2AUoC8zA cnn topstories?d=7Q72WNTAKBA cnn topstories?i=u6ih4WV0Brw:rpii4NTbU0U:V sGLiPBpWU cnn topstories?d=qj6IDK7rITs cnn topstories?i=u6ih4WV0Brw:rpii4NTbU0U:gIN9vFwOqvQ

u6ih4WV0Brw
Eli Lilly and Company’s monoclonal antibody combination therapy reduced virus levels, hospitalizations and emergency room visits in patients with mild-to-moderate Covid-19, the pharmaceutical company said Wednesday.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *